Obesity is associated with significant health risks including stroke and heart disease. The prevalence of obesity has dramatically increased over the past 20 years. Although the development of obesity is clearly related to changing lifestyles, the central nervous system plays a key role in regulation of energy balance. To develop effective strategies for treating obesity, we must gain a clearer understanding of the neuro-circuitry and signaling mechanisms involved. Toward this end, recent progress has been made in the understanding of the roles played by the sensory circumventricular organs (CVOs) of the brain. These areas lack the normal blood-brain barrier and thus act as transducers of signals between the blood, other centers in the brain, and the cerebrospinal fluid. This review focuses on the roles played by the sensory CVOs in detecting and responding to a number of signals that carry information regarding nutritional status, including cholecystokinin, amylin, ghrelin, peptide YY, pancreatic polypeptide, leptin, adiponectin, and glucose.
Get full access to this article
View all access options for this article.
References
1.
Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab89:2522–2525, 2004.
2.
Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science299:853–855, 2003.
3.
Berthoud HR. Neural control of appetite: cross-talk between homeostatic and non-homeostatic systems. Appetite43:315–317, 2004.
4.
Williams G, Harrold JA, Cutler DJ. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc Nutr Soc59:385–396, 2000.
5.
Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell104:531–543, 2001.
6.
Grill HJ, Kaplan JM. The neuroanatomical axis for control of energy balance. Front Neuroendocrinol23:2–40, 2002.
7.
Hofbauer KG. Molecular pathways to obesity. Int J Obes Relat Metab Disord26(Suppl 2):S18–S27, 2002.
8.
Levin BE. Metabolic sensors: viewing glucosensing neurons from a broader perspective. Physiol Behav76:397–401, 2002.
9.
Saper CB, Chou TC, Elmquist JK. The need to feed: homeostatic and hedonic control of eating. Neuron36:199–211, 2002.
10.
Jobst EE, Enriori PJ, Cowley MA. The electrophysiology of feeding circuits. Trends Endocrinol Metab15:488–499, 2004.
11.
Baura GD, Foster DM, Porte D, Jr, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest92:1824–1830, 1993.
12.
Banks WA, Kastin AJ. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides19: 883–889, 1998.
13.
Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides17:305–311, 1996.
14.
Pan W, Yu Y, Cain CM, Nyberg F, Couraud PO, Kastin AJ. Permeation of growth hormone across the blood-brain barrier. Endocrinology146:4898–4904, 2005.
15.
Wislocki GB, Putnam JT. Note on the anatomy of the areae postremae. Anat Rec19:281–285, 1920.
16.
Wislocki GB, Putnam JT. Further observations on the anatomy and physiology of the areae postremae. Anat Rec27:151, 1924.
17.
Wislocki GB, King LS. The permeability of the hypophysis and hypothalamus to vital dyes, with a study of the hypophyseal vascular supply. Am J Anat58:421–472, 1936.
18.
Wislocki GB, Leduc EH. Vital staining of the hematoencephalic barrier by silver nitrate and trypan blue, with cytological comparisons of the neurohypophysis, pineal body, area postrema, intercolumnal tubercle, and supraoptic crest. J Comp Neurol96:371–414, 1952.
19.
Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J7:678–686, 1993.
20.
Rodriguez EM, Herrera H, Peruzzo B, Rodriguez S, Hein S, Oksche A. Light- and electron-microscopic immunocytochemistry and lectin histochemistry of the subcommissural organ: evidence for processing of the secretory material. Cell Tissue Res243:545–559, 1986.
21.
Banks WA, Jaspan JB, Huang W, Kastin AJ. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides18:1423–1429, 1997.
22.
Banks WA, Kastin AJ, Maness LM, Huang W, Jaspan JB. Permeability of the blood-brain barrier to amylin. Life Sci57:1993–2001, 1995.
23.
Rethelyi M. Diffusional barrier around the hypothalamic arcuate nucleus in the rat. Brain Res307:355–358, 1984.
24.
Maness LM, Kastin AJ, Farrell CL, Banks WA. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology139:4556–4562, 1998.
25.
Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature411:480–484, 2001.
26.
Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron37:649–661, 2003.
27.
Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther302:822–827, 2002.
28.
McKinley MJ, McAllen RM, Davern P, Giles ME, Penschow J, Sunn N, Uschakov A, Oldfield BJ. The sensory circumventricular organs of the mammalian brain. Adv Anat Embryol Cell Biol172:111–122, 2003.
29.
Dellmann HD, Simpson JB. The subfornical organ. Int Rev Cytol58: 333–421, 1979.
30.
Gross PM. Morphology and physiology of capillary systems in subregions of the subfornical organ and area postrema. Can J Physiol Pharmacol69:1010–1025, 1991.
31.
Rhodes CH, Morrell JI, Pfaff DW. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J Comp Neurol198:45–64, 1981.
32.
Miselis RR. The subfornical organ’s neural connections and their role in water balance. Peptides3:501–502, 1982.
33.
Miselis RR, Shapiro RE, Hand PJ. Subfornical organ efferents to neural systems for control of body water. Science205:1022–1025, 1979.
34.
Ferguson AV, Day TA, Renaud LP. Subfornical organ stimulation excites paraventricular neurons projecting to dorsal medulla. Am J Physiol247:R1088–R1092, 1984.
35.
Lind RW, Van Hoesen GW, Johnson AK. An HRP study of the connections of the subfornical organ of the rat. J Comp Neurol210: 265–277, 1982.
36.
Weiss ML, Hatton GI. Collateral input to the paraventricular and supraoptic nuclei in rat, I: afferents from the subfornical organ and the anteroventral third ventricle region. Brain Res Bull24:231–238, 1990.
37.
Lind RW. Bi-directional, chemically specified neural connections between the subfornical organ and the midbrain raphe system. Brain Res384:250–261, 1986.
38.
Swanson LW, Lind RW. Neural projections subserving the initiation of a specific motivated behavior in the rat: new projections from the subfornical organ. Brain Res379:399–403, 1986.
39.
Tanaka J, Ushigome A, Hori K, Nomura M. Responses of raphe nucleus projecting subfornical organ neurons to angiotensin II in rats. Brain Res Bull45:315–318, 1998.
40.
Zardetto-Smith AM, Gray TS. A direct neural projection from the nucleus of the solitary tract to the subfornical organ in the rat. Neurosci Lett80:163–166, 1987.
41.
Cottrell GT, Ferguson AV. Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept117:11–23, 2004.
42.
McKinley MJ, Allen AM, Burns P, Colvill LM, Oldfield BJ. Interaction of circulating hormones with the brain: the roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol25(Suppl):S61–S67, 1998.
43.
Giles ME, Fernley RT, Nakamura Y, Moeller I, Aldred GP, Ferraro T, Penschow JD, McKinley MJ, Oldfield BJ. Characterization of a specific antibody to the rat angiotensin II AT1 receptor. J Histochem Cytochem47:507–516, 1999.
44.
Armstrong WE, Tian M, Wong H. Electron microscopic analysis of synaptic inputs from the median preoptic nucleus and adjacent regions to the supraoptic nucleus in the rat. J Comp Neurol373:228–239, 1996.
45.
Camacho A, Phillips MI. Horseradish peroxidase study in rat of the neural connections of the organum vasculosum of the lamina terminalis. Neurosci Lett25:201–204, 1981.
46.
Sawchenko PE, Swanson LW. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J Comp Neurol218:121–144, 1983.
47.
Phillips MI, Camacho A. Neural connections of the organum vasculosum of the lamina terminalis. In: Gross P, Ed. Circum-ventricular Organs and Body Fluids. Boca Raton: CRC Press, 1987: 157–69.
48.
Saper CB, Levisohn D. Afferent connections of the median preoptic nucleus in the rat: anatomical evidence for a cardiovascular integrative mechanism in the anteroventral third ventricular (AV3V) region. Brain Res288:21–31, 1983.
49.
Merchenthaler I, Liposits Z. Mapping of thyrotropin-releasing hormone (TRH) neuronal systems of rat forebrain projecting to the median eminence and the OVLT. Immunocytochemistry combined with retrograde labeling at the light and electron microscopic levels. Acta Biol Hung45:361–374, 1994.
50.
Chernicky CL, Barnes KL, Conomy JP, Ferrario CM. A morphological characterization of the canine area postrema. Neurosci Lett20: 37–43, 1980.
51.
Lanca AJ, van der KD. A serotonin-containing pathway from the area postrema to the parabrachial nucleus in the rat. Neuroscience14: 1117–1126, 1985.
52.
Shapiro RE, Miselis RR. The central neural connections of the area postrema of the rat. J Comp Neurol234:344–364, 1985.
53.
van der KD, Koda LY. Organization of the projections of a circumventricular organ: the area postrema in the rat. J Comp Neurol20;219:328–338, 1983.
54.
Ciriello J, Hrycyshyn AW, Calaresu FR. Glossopharyngeal and vagal afferent projections to the brain stem of the cat: a horseradish peroxidase study. J Auton Nerv Syst4:63–79, 1981.
55.
Davies RO, Kalia M. Carotid sinus nerve projections to the brain stem in the cat. Brain Res Bull6:531–541, 1981.
56.
Kalia M, Mesulam MM. Brain stem projections of sensory and motor components of the vagus complex in the cat: II. Laryngeal, tracheobronchial, pulmonary, cardiac, and gastrointestinal branches. J Comp Neurol193:467–508, 1980.
57.
Larsson LI, Rehfeld JF. Distribution of gastrin and CCK cells in the rat gastrointestinal tract. Evidence for the occurrence of three distinct cell types storing COOH-terminal gastrin immunoreactivity. Histochemistry58:23–31, 1978.
58.
Lilja P, Wiener I, Inoue K, Fried GM, Greeley GH, Jr, Thompson JC. Release of cholecystokinin in response to food and intraduodenal fat in pigs, dogs and man. Surg Gynecol Obstet159:557–561, 1984.
59.
Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol84:488–495, 1973.
60.
Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr34:154–160, 1981.
Day HE, McKnight AT, Poat JA, Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology33:719–727, 1994.
63.
Sayegh AI, Ritter RC. Vagus nerve participates in CCK-induced Fos expression in hindbrain but not myenteric plexus. Brain Res878:155–162, 2000.
64.
Hoffman GE, Smith MS, Verbalis JG. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol14:173–213, 1993.
65.
Sun K, Ferguson AV. Cholecystokinin activates area postrema neurons in rat brain slices. Am J Physiol272:R1625–R1630, 1997.
66.
Carpenter DO, Briggs DB, Knox AP, Strominger N. Excitation of area postrema neurons by transmitters, peptides, and cyclic nucleotides. J Neurophysiol59:358–369, 1988.
67.
Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A84: 8628–8632, 1987.
68.
Westermark P, Wernstedt C, O’Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol127:414–417, 1987.
69.
Gedulin BR, Rink TJ, Young AA. Dose-response for glucagonostatic effect of amylin in rats. Metabolism46:67–70, 1997.
70.
Silvestre RA, Peiro E, Degano P, Miralles P, Marco J. Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept31:23–31, 1990.
71.
Peiro E, Degano P, Silvestre RA, Marco J. Inhibition of insulin release by amylin is not mediated by changes in somatostatin output. Life Sci49:761–765, 1991.
72.
Degano P, Silvestre RA, Salas M, Peiro E, Marco J. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul Pept43:91–96, 1993.
73.
Broderick CL, Brooke GS, DiMarchi RD, Gold G. Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets. Biochem Biophys Res Commun177:932–938, 1991.
74.
Silvestre RA, Rodriguez-Gallardo J, Gutierrez E, Marco J. Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion. Study in the perfused rat pancreas. Regul Pept68:31–35, 1997.
75.
Young DA, Deems RO, Deacon RW, McIntosh RH, Foley JE. Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. Am J Physiol259:E457–E461, 1990.
76.
Lutz TA, Del PE, Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav55: 891–895, 1994.
77.
Lutz TA, Del PE, Scharrer E. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides16:457–462, 1995.
78.
Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC. Amylin: a novel action in the brain to reduce body weight. Endocrinology141: 850–853, 2000.
79.
Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience62:553–567, 1994.
80.
Christopoulos G, Paxinos G, Huang XF, Beaumont K, Toga AW, Sexton PM. Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol73:1037–1041, 1995.
81.
Paxinos G, Chai SY, Christopoulos G, Huang XF, Toga AW, Wang HQ, Sexton PM. In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain. J Chem Neuroanat27:217–236, 2004.
82.
Barth SW, Riediger T, Lutz TA, Rechkemmer G. Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat. Brain Res997:97–102, 2004.
83.
Riediger T, Schmid HA, Lutz T, Simon E. Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am J Physiol Regul Integr Comp Physiol281:R1833–R1843, 2001.
84.
Riediger T, Schmid HA, Lutz TA, Simon E. Amylin and glucose co-activate area postrema neurons of the rat. Neurosci Lett328:121–124, 2002.
85.
Riediger T, Schmid HA, Young AA, Simon E. Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones. Brain Res837:161–168, 1999.
86.
Riediger T, Rauch M, Schmid HA. Actions of amylin on subfornical organ neurons and on drinking behavior in rats. Am J Physiol276: R514–R521, 1999.
87.
Pulman KJ, Fry WM, Cottrell GT, Ferguson AV. The subfornical organ: a central target for circulating feeding signals. J Neurosci26: 2022–2030, 2006.
88.
Del PE, Schade B, Riediger T, Lutz TA, Scharrer E. Effects of amylin and salmon calcitonin on feeding and drinking behavior in pygmy goats. Physiol Behav75:593–599, 2002.
89.
Bottcher G, Alumets J, Hakanson R, Sundler F. Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man: an electron microscopic study. Regul Pept13:283–291, 1986.
90.
Greeley GH, Jr, Jeng YJ, Gomez G, Hashimoto T, Hill FL, Kern K, Kurosky T, Chuo HF, Thompson JC. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology124:1438–1443, 1989.
91.
Eberlein GA, Eysselein VE, Schaeffer M, Layer P, Grandt D, Goebell H, Niebel W, Davis M, Lee TD, Shively JE. A new molecular form of PYY: structural characterization of human PYY(3–36) and PYY(1–36). Peptides10:797–803, 1989.
92.
Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR, Jr. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36. Regul Pept51:151–159, 1994.
93.
Murphy KG, Bloom SR. Gut hormones in the control of appetite. Exp Physiol89:507–516, 2004.
94.
Track NS, McLeod RS, Mee AV. Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations. Can J Physiol Pharmacol58:1484–1489, 1980.
95.
Grove KL, Chen P, Koegler FH, Schiffmaker A, Susan SM, Cameron JL. Fasting activates neuropeptide Y neurons in the arcuate nucleus and the paraventricular nucleus in the rhesus macaque. Brain Res Mol Brain Res113:133–138, 2003.
96.
Singer LK, Kuper J, Brogan RS, Smith MS, Grove KL. Novel expression of hypothalamic neuropeptide Y during postnatal development in the rat. Neuroreport11:1075–1080, 2000.
97.
Grove KL, Brogan RS, Smith MS. Novel expression of neuropeptide Y (NPY) mRNA in hypothalamic regions during development: region-specific effects of maternal deprivation on NPY and Agouti-related protein mRNA. Endocrinology142:4771–4776, 2001.
98.
Morris BJ. Neuronal localisation of neuropeptide Y gene expression in rat brain. J Comp Neurol290:358–368, 1989.
99.
Gehlert DR, Chronwall BM, Schafer MP, O’Donohue TL. Localization of neuropeptide Y messenger ribonucleic acid in rat and mouse brain by in situ hybridization. Synapse1:25–31, 1987.
100.
Kagotani Y, Hisano S, Tsuruo Y, Daikoku S, Chihara K. Vasopressin-deficient paraventricular magnocellular neurons of homozygous Brattleboro rats synthesize neuropeptide Y. Neurosci Lett112:37–42, 1990.
101.
Lundberg JM, Terenius L, Hokfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand116:477–480, 1982.
102.
Balasubramaniam AA. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides18:445–457, 1997.
103.
Herzog H. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol480:21–29, 2003.
104.
Dumont Y, St-Pierre JA, Quirion R. Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport7:901–904, 1996.
105.
Dumont Y, Fournier A, St-Pierre S, Quirion R. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3–36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse22:139–158, 1996.
106.
Larsen PJ, Kristensen P. The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex. Brain Res Mol Brain Res48:1–6, 1997.
107.
Dumont Y, Fournier A, Quirion R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J Neurosci18:5565–5574, 1998.
108.
Migita K, Loewy AD, Ramabhadran TV, Krause JE, Waters SM. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Res889:23–37, 2001.
109.
Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H, Hollenberg AN, Friedman JM, Elmquist JK. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol482:217–243, 2005.
110.
Campbell RE, Ffrench-Mullen JM, Cowley MA, Smith MS, Grove KL. Hypothalamic circuitry of neuropeptide Y regulation of neuro-endocrine function and food intake via the Y5 receptor subtype. Neuroendocrinology74:106–119, 2001.
111.
Allen JM, Fitzpatrick ML, Yeats JC, Darcy K, Adrian TE, Bloom SR. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion30:255–262, 1984.
112.
Yang H. Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides23:349–358, 2002.
113.
Bonaz B, Taylor I, Tache Y. Peripheral peptide YY induces c-fos–like immunoreactivity in the rat brain. Neurosci Lett163:77–80, 1993.
Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, Ghatei MA, Bloom SR. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab88:3989–3992, 2003.
116.
Halatchev IG, Ellacott KL, Fan W, Cone RD. Peptide YY3–36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology145:2585–2590, 2004.
117.
Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, Klaus S, Thone-Reineke C, Benoit SC, Seeley RJ, Beck-sickinger AG, Koglin N, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Ortmann S, Castaneda TR, Tschop M. PYY3–36 as an anti-obesity drug target. Obes Rev6:307–322, 2005.
118.
Tschop M, Castaneda TR, Joost HG, Thone-Reineke C, Ortmann S, Klaus S, Hagan MM, Chandler PC, Oswald KD, Benoit SC, Seeley RJ, Kinzig KP, Moran TH, Beck-sickinger AG, Koglin N, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Schindler M, Arndt K, Rudolf K, Mark M, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Craney S, Flora D, Smiley D, Heiman ML. Physiology: does gut hormone PYY3–36 decrease food intake in rodents? Nature430:1, 2004.
119.
Clark JT, Sahu A, Kalra PS, Balasubramaniam A, Kalra SP. Neuropeptide Y (NPY)–induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([nor-Leu4]NPY) and peptide YY. Regul Pept17:31–39, 1987.
120.
Acuna-Goycolea C, van den Pol AN. Peptide YY(3–36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J Neurosci25:10510–10519, 2005.
121.
Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Niijima A, Meguid MM, Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology124:1325–1336, 2003.
122.
Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care5:391–395, 2002.
123.
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes50:1714–1719, 2001.
124.
Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature19;407:908–913, 2000.
125.
Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology141:4325–4328, 2000.
Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR. Ghrelin causes hyperphagia and obesity in rats. Diabetes50:2540–2547, 2001.
128.
Petersenn S. Growth hormone secretagogues and ghrelin: an update on physiology and clinical relevance. Horm Res58(Suppl 3):56–61, 2002.
129.
Hewson AK, Dickson SL. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol12:1047–1049, 2000.
130.
Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secreta-gogue, on hypothalamic peptide gene expression. Endocrinology141: 4797–4800, 2000.
131.
Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron37:649–661, 2003.
132.
van den TM, Lee K, Whyment AD, Blanks AM, Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci7:493–494, 2004.
133.
Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem271:10697–10703, 1996.
134.
Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun221:286–289, 1996.
135.
Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem270:26746–26749, 1995.
136.
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev26:439–451, 2005.
137.
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med7: 947–953, 2001.
138.
Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest108:1875–1881, 2001.
139.
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med7: 941–946, 2001.
140.
Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS. Adiponectin acts in the brain to decrease body weight. Nat Med10:524–529, 2004.
141.
Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tschop M, Banks WA. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes55:141–147, 2006.
142.
Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med1:1155–1161, 1995.
143.
Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature382:250–252, 1996.
144.
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science269:543–546, 1995.
145.
Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol24:225–253, 2003.
146.
Ahima RS. Central actions of adipocyte hormones. Trends Endocrinol Metab16:307–313, 2005.
147.
Mercer JG, Moar KM, Hoggard N. Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology139:29–34, 1998.
148.
Shioda S, Funahashi H, Nakajo S, Yada T, Maruta O, Nakai Y. Immunohistochemical localization of leptin receptor in the rat brain. Neurosci Lett243:41–44, 1998.
149.
Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology143:239–246, 2002.
150.
Mercer JG, Moar KM, Findlay PA, Hoggard N, Adam CL. Association of leptin receptor (OB-Rb), NPY and GLP-1 gene expression in the ovine and murine brainstem. Regul Pept75–76:271–278, 1998.
151.
Emond M, Schwartz GJ, Ladenheim EE, Moran TH. Central leptin modulates behavioral and neural responsivity to CCK. Am J Physiol276:R1545–R1549, 1999.
152.
Ladenheim EE, Emond M, Moran TH. Leptin enhances feeding suppression and neural activation produced by systemically administered bombesin. Am J Physiol Regul Integr Comp Physiol289: R473–R477, 2005.
153.
Morton GJ, Blevins JE, Williams DL, Niswender KD, Gelling RW, Rhodes CJ, Baskin DG, Schwartz MW. Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest115: 703–710, 2005.
154.
Mayer J, Bates MW. Blood glucose and food intake in normal and hypophysectomized, alloxan-treated rats. Am J Physiol168:812–819, 1952.
155.
Stephens DB, Baldwin BA. The lack of effect of intrajugular or intraportal injections of glucose or amino-acids on food intake in pigs. Physiol Behav12:923–929, 1974.
156.
Bellinger LL, Trietley GJ, Bernardis LL. Failure of portal glucose and adrenaline infusions or liver denervation to affect food intake in dogs. Physiol Behav16:299–304, 1976.
157.
Strubbe JH, Steffens AB. Blood glucose levels in portal and peripheral circulation and their relation to food intake in the rat. Physiol Behav19:303–307, 1977.
158.
Thompson DA, Campbell RG. Hunger in humans induced by 2-deoxy-d-glucose: glucoprivic control of taste preference and food intake. Science198:1065–1068, 1977.
159.
Smith GP, Epstein AN. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol217:1083–1087, 1969.
160.
Houpt TR, Hance HE. Stimulation of food intake in the rabbit and rat by inhibition of glucose metabolism with 2-deoxy-d-glucose. J Comp Physiol Psychol76:395–400, 1971.
161.
Kadekaro M, Timo-Iaria C, Valle LE. Neural systems responsible for the gastric secretion provoked by 2-deoxy-d-glucose cytoglucopoenia. J Physiol252:565–584, 1975.
162.
Rowland N, Watkins L, Carlton J. Failure of 2-deoxy-d-glucose to stimulate feeding in deermice. Physiol Behav34:155–157, 1985.
163.
Miselis RR, Epstein AN. Feeding induced by intracerebroventricular 2-deoxy-d-glucose in the rat. Am J Physiol229:1438–1447, 1975.
164.
Slusser PG, Ritter RC. Increased feeding and hyperglycemia elicited by intracerebroventricular 5-thioglucose. Brain Res202:474–478, 1980.
165.
Ritter RC, Slusser PG, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science213:451–452, 1981.
166.
Ritter S, Taylor JS. Vagal sensory neurons are required for lipoprivic but not glucoprivic feeding in rats. Am J Physiol258:R1395–R1401, 1990.
167.
Ritter S, Dinh TT. 2-Mercaptoacetate and 2-deoxy-d-glucose induce Fos-like immunoreactivity in rat brain. Brain Res641:111–120, 1994.
168.
Contreras RJ, Fox E, Drubovich ML. Area postrema lesions produce feeding deficits in the rat: effects of preoperative dieting and 2-deoxy-d-glucose. Physiol Behav29:875–884, 1982.
169.
Edmonds BK, Edwards GL. Dorsomedial hindbrain participation in glucoprivic feeding response to 2DG but not 2DG-induced hyper-glycemia or activation of the HPA axis. Brain Res801:21–28, 1998.
170.
Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes51:2056–2065, 2002.
171.
Adachi A, Kobashi M, Funahashi M. Glucose-responsive neurons in the brainstem. Obes Res3(Suppl 5):735S–740S, 1995.
172.
Funahashi M, Adachi A. Glucose-responsive neurons exist within the area postrema of the rat: in vitro study on the isolated slice preparation. Brain Res Bull32:531–535, 1993.
173.
Patil GD, Briski KP. Lactate is a critical "sensed" variable in caudal hindbrain monitoring of CNS metabolic stasis. Am J Physiol Regul Integr Comp Physiol289:R1777–R1786, 2005.
174.
Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress" ? Am J Hum Genet14:353–362, 1962.
Commins SP, Watson PM, Frampton IC, Gettys TW. Leptin selectively reduces white adipose tissue in mice via a UCP1-dependent mechanism in brown adipose tissue. Am J Physiol Endocrinol Metab280:E372–E377, 2001.
177.
Commins SP, Watson PM, Padgett MA, Dudley A, Argyropoulos G, Gettys TW. Induction of uncoupling protein expression in brown and white adipose tissue by leptin. Endocrinology140:292–300, 1999.
178.
Tsubone T, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept130: 97–103, 2005.
179.
Zorrilla EP, Inoue K, Fekete EM, Tabarin A, Valdez GR, Koob GF. Measuring meals: structure of prandial food and water intake of rats. Am J Physiol Regul Integr Comp Physiol288:R1450–R1467, 2005.
180.
Rossi R, Scharrer E. Circadian patterns of drinking and eating in pygmy goats. Physiol Behav51:895–897, 1992.
181.
Fitzsimons TJ, Le MJ. Eating as a regulatory control of drinking in the rat. J Comp Physiol Psychol67:273–283, 1969.
182.
Robinson EA, Adolf EF. Pattern of normal water drinking in dogs. Am J Physiol139:39–44, 1943.
183.
Ikemura R, Matsuwaki T, Yamanouchi K, Nishihara M. Involvement of endogenous vasopressin in high plasma osmolality-induced anorexia via V1 receptor-mediated mechanism. J Vet Med Sci66: 951–955, 2004.
184.
Edwards GL, Ritter RC. Ablation of the area postrema causes exaggerated consumption of preferred foods in the rat. Brain Res216: 265–276, 1981.
185.
Ritter RC, Edwards GL. Area postrema lesions cause overconsumption of palatable foods but not calories. Physiol Behav32:923–927, 1984.
186.
Edwards GL, Ritter RC. Area postrema lesions increase drinking to angiotensin and extracellular dehydration. Physiol Behav29:943–947, 1982.
